Last published articles

Hearing loss is on the rise.

Low- and middle-income countries face more challenges.

Key challenges are access disparities and lack of reimbursement policies.

Hearing care should be integrated into the national primary healthcare.

Organizations like HEARRING can promote education and awareness.

Dupilumab improved EOM severity and CT scores in patients with concomitant ECRS.

Air-conductive hearing in EOM patients improved significantly with dupilumab.

Dupilumab reduced steroid use in EOM patients, suggesting long-term benefits.

EOM treatment has shifted significantly with dupilumab use for concomitant ECRS.

Dupilumab is highly effective in treating EOM, improving clinical outcomes.

There are no studies about the models for predicting recurrence in LAPTC.

We established a nomogram for predicting 3- and 5-year RFS of LAPTC patients.

The number of LAPTC patients is relatively larger than other study.

Tympanomeatal flap advancement increases otomycosis risk by creating epithelial gaps.

Adhered cerumen removal damages the epithelial barrier, raising otomycosis risk.

Otomycosis does not impact tympanoplasty graft success.

Individuals with somatosensory tinnitus experience higher annoyance.

Stress and sleep disturbances are factors associated with the somatosensory tinnitus.

The somatosensory influence causes a greater impact of tinnitus on quality of life.

The somatosensory system must be considered when evaluating and managing tinnitus.

Preterm birth, NHB and AMA are potential risk factors of hearing impairment.

Mutations such as c.235delC in GJB2 and c.919-2A>G in SLC26A4 are the most common.

Deafness gene screening for neonates is important for diagnosis and intervention.

Asymmetric graft design accommodates malleus angulation and membrane obliquity.

Asymmetric design avoids posterior canal contact, suits neutral configuration.

Larger anterior portion promotes optimal contact with tympanic membrane remnant.

Asymmetric graft design improves success rate, contributes to better hearing gain.

We compared the outcomes of patients undergoing VANS versus open lobectomy.

No significant differences were observed in adverse events between two groups.

Our VANS technique could be a good option in thyroid lobectomy.

Modified VPB lowers PCF post-TLE for H&N cancers.

Modified VPB: lower PCF, shorter hospital stay.

Multivariable analysis confirms modified VPB independently protects against PCF.

Modified VPB is potential to be an alternative process.